Johnson & Johnson (JNJ)
NYSE·Healthcare·Drug Manufacturers - General
$227.06
+0.80%
Mkt Cap $555.94B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 14, 2026 | $23.61B | $24.06B | +1.89% | $2.68 | $2.70 | +0.75% | — | — |
| Q1 2026 Jan 21, 2026 | $24.15B | $24.56B | +1.72% | $2.46 | $2.46 | +0.00% | — | — |
| Q4 2025 Oct 14, 2025 | $23.76B | $23.99B | +1.00% | $2.76 | $2.80 | +1.45% | — | — |
| Q3 2025 Jul 16, 2025 | $22.85B | $23.74B | +3.89% | $2.68 | $2.77 | +3.36% | — | — |
| Q2 2025 Apr 15, 2025 | $21.56B | $21.89B | +1.55% | $2.58 | $2.77 | +7.36% | — | — |
| Q1 2025 Jan 22, 2025 | $22.43B | $22.52B | +0.40% | $1.99 | $2.04 | +2.51% | — | — |
| Q4 2024 Oct 15, 2024 | $22.17B | $22.47B | +1.35% | $2.21 | $2.42 | +9.50% | — | — |
| Q3 2024 Jul 17, 2024 | $22.33B | $22.45B | +0.52% | $2.71 | $2.82 | +4.06% | — | — |
| Q2 2024 Apr 16, 2024 | $21.40B | $21.38B | -0.08% | $2.64 | $2.71 | +2.65% | — | — |
| Q1 2024 Jan 23, 2024 | $20.99B | $21.39B | +1.93% | $2.27 | $2.29 | +0.88% | — | — |
| Q4 2023 Oct 17, 2023 | $19.83B | $21.35B | +7.67% | $2.52 | $2.66 | +5.56% | — | — |
| Q3 2023 Jul 20, 2023 | $24.63B | $21.52B | -12.61% | $2.61 | $2.80 | +7.28% | — | — |
| Q2 2023 Apr 18, 2023 | $23.69B | $20.89B | -11.79% | $2.51 | $2.68 | +6.77% | — | — |
| Q1 2023 Jan 24, 2023 | $23.88B | $23.71B | -0.73% | $2.22 | $2.35 | +5.86% | — | — |
| Q4 2022 Oct 18, 2022 | $23.36B | $20.00B | -14.39% | $2.49 | $2.55 | +2.41% | — | — |
| Q3 2022 Jul 19, 2022 | $23.77B | $24.02B | +1.05% | $2.57 | $2.59 | +0.78% | — | — |
| Q2 2022 Apr 19, 2022 | $23.62B | $23.43B | -0.84% | $2.60 | $2.67 | +2.69% | — | — |
| Q1 2022 Jan 25, 2022 | $23.81B | $24.80B | +4.19% | $2.12 | $2.13 | +0.47% | — | — |
| Q4 2021 Oct 19, 2021 | $23.70B | $23.34B | -1.54% | $2.37 | $2.60 | +9.70% | — | — |
| Q3 2021 Jul 21, 2021 | $23.81B | $23.31B | -2.09% | $2.27 | $2.48 | +9.25% | — | — |